The Malmö International Brother Study (MIBS)
NCT00231751 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2005-10-04
Summary
Existing data support the concept that a genetic predisposition for inhibitor development exists. The aim of the Malmö International Brother Study (MIBS) is to evaluate genetic factors associated with the development of inhibitory antibodies in patients with hemophilia.
Conditions
- Hemophilia A With Inhibitors
Sponsors & Collaborators
-
Skane University Hospital
lead OTHER
Principal Investigators
-
Jan Astermark, M.D., Ph.D. · Skane University Hospital
Eligibility
- Min Age
- 0 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-11-30
- Completion
- 2004-06-30
Countries
- Sweden
Study Locations
More Related Trials
-
Efficacy Study of Activated Prothrombin Complex for Prevention of Bleeds in Hemophilia A With Inhibitors
NCT00221195 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
NCT05611801 ·Status: RECRUITING ·Phase: PHASE3
-
Epidemiology and Immunology of Hemophilia A Inhibitors
NCT00005518 ·Status: COMPLETED
-
Study Evaluating Inhibitor Specificity in Hemophilia A
NCT00151385 ·Status: WITHDRAWN ·Phase: PHASE4
-
An Observational Study to Evaluate Physical Activity, Bleeding Incidence and Health Related Quality of Life, in Participants With Haemophilia A Without Inhibitors Receiving Standard of Care Treatment
NCT04165135 ·Status: COMPLETED
-
Bleeding Symptoms of Carriers of Hemophilia A and B
NCT01029808 ·Status: COMPLETED
-
Chronic Pain and Hemophilia
NCT05202951 ·Status: RECRUITING
-
A Study of Recombinant AAV2/6 Human Factor 8 Gene Therapy SB-525 (PF-07055480) in Subjects With Severe Hemophilia A
NCT03061201 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Recombinant Factor IX Product, IB1001, in Previously Treated Pediatric Subjects With Hemophilia B
NCT01271868 ·Status: TERMINATED ·Phase: PHASE3
-
The Dynamic Interplay Between Bleeding Phenotype and Baseline Factor Level in Moderate and Mild Hemophilia A and B
NCT03623295 ·Status: COMPLETED
-
A Feasibility Study to Collect Data in Patients With Haemophilia
NCT00798499 ·Status: COMPLETED
-
Study of Recombinant Factor IX Product, IB1001, in Subjects With Hemophilia B
NCT00768287 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Efficacy of BAY94-9027 in Previously Treated Male Children With Haemophilia A
NCT01775618 ·Status: COMPLETED ·Phase: PHASE3
-
EVALUATION of the OVERALL HAEMOSTATIC CAPACITY of MIM8 with GLOBAL HAEMOSTASIS ASSAYS and FIBRIN CLOT ULTRASTRUCTURE
NCT06212505 ·Status: COMPLETED
-
A Study to Evaluate the Safest Dose Range for FEIBA in Hemophilia A Patients With Inhibitors on Emicizumab
NCT04205175 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
2-cohort Study of Adult Patients With Severe Hemophilia A in Greece
NCT02319070 ·Status: COMPLETED
-
Hemlibra in Mild Hemophilia A
NCT04567511 ·Status: RECRUITING ·Phase: PHASE4
-
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
NCT05145127 ·Status: RECRUITING ·Phase: PHASE3
-
A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Emicizumab in Participants With Mild or Moderate Hemophilia A Without FVIII Inhibitors
NCT04158648 ·Status: COMPLETED ·Phase: PHASE3
-
Females With Severe or Moderate Hemophilia A or B: an International Multi-center Study
NCT00936312 ·Status: COMPLETED
-
HemFitBit, an Observational Study of Physical Activity in People With Moderate and Severe Haemophilia A
NCT04181697 ·Status: COMPLETED
-
Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia
NCT01988532 ·Status: COMPLETED
-
Learning to Live With Non-severe Haemophilia
NCT05314751 ·Status: COMPLETED
-
Phenotypic Heterogeneity in Hemophilia A: An Investigation of the Role of Platelet Function
NCT02225483 ·Status: COMPLETED
-
A Non-interventional Retrospective Study of the Current Treatment Practice in European Haemophilia Care
NCT02049099 ·Status: COMPLETED